NEW DELHI: US pharma giant Johnson and Johnson on Friday said it has applied for Emergency Use Authorization (EUA) of its single-dose Covid-19 vaccine Janssen to the Government of India. A statement issued by the company on Thursday read, “On 5th August 2021 Johnson and Johnson Pvt. Ltd applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine to the Government of India.” The pharma company stated that it is an important milestone that paves the way to bringing the single-dose Covid-19 vaccine to the people of India, and the rest of the world.